Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Mem. Inst. Oswaldo Cruz ; 104(8): 1083-1090, Dec. 2009. ilus, tab
Article Dans Anglais | LILACS | ID: lil-538167

Résumé

Gap junction connexin-43 (Cx43) molecules are responsible for electrical impulse conduction in the heart and are affected by transforming growth factor-â (TGF-â). This cytokine increases during Trypanosoma cruzi infection, modulating fibrosis and the parasite cell cycle. We studied Cx43 expression in cardiomyocytes exposed or not to TGF-â T. cruzi, or SB-431542, an inhibitor of TGF-â receptor type I (ALK-5). Cx43 expression was also examined in hearts with dilated cardiopathy from chronic Chagas disease patients, in which TGF-â signalling had been shown previously to be highly activated. We demonstrated that TGF-â treatment induced disorganised gap junctions in non-infected cardiomyocytes, leading to a punctate, diffuse and non-uniform Cx43 staining. A similar pattern was detected in T. cruzi-infected cardiomyocytes concomitant with high TGF-â secretion. Both results were reversed if the cells were incubated with SB-431542. Similar tests were performed using human chronic chagasic patients and we confirmed a down-regulation of Cx43 expression, an altered distribution of plaques in the heart and a significant reduction in the number and length of Cx43 plaques, which correlated negatively with cardiomegaly. We conclude that elevated TGF-â levels during T. cruzi infection promote heart fibrosis and disorganise gap junctions, possibly contributing to abnormal impulse conduction and arrhythmia that characterise severe cardiopathy in Chagas disease.


Sujets)
Adulte , Animaux , Femelle , Humains , Mâle , Souris , Adulte d'âge moyen , Benzamides/usage thérapeutique , Maladie de Chagas/métabolisme , /métabolisme , Dioxoles/usage thérapeutique , Jonctions communicantes/métabolisme , Myocytes cardiaques/composition chimique , Récepteurs TGF-bêta/antagonistes et inhibiteurs , Facteur de croissance transformant bêta/usage thérapeutique , Maladie de Chagas/traitement médicamenteux , Technique d'immunofluorescence , Jonctions communicantes/effets des médicaments et des substances chimiques , Immunohistochimie , Microscopie confocale , Myocytes cardiaques/effets des médicaments et des substances chimiques , Myocytes cardiaques/métabolisme
SÉLECTION CITATIONS
Détails de la recherche